Bian, He-Tao
Wang, Xia
Liu, Gui-You
Zhou, Chen
Meng, Ran
Liu, Lan
Duan, Jian-Gang
Yan, Feng
Li, Chuan-Hui
Li, Min
Hui, Wen
Zhang, Xu-Xiang
Zhao, Dong
Li, Ya-Peng
Fang, Qi
Kang, De-Zhi
Zeng, Hong-Liang
Liang, Zhi-Jian
Shi, Zheng-Hao
Yue, Wei
Sun, Qin-Jian
Chen, Gui-Sheng
Song, Jian-Long
Yan, Zhong-Rui
Ji, Qiu-Hong
Wang, Kai-Jie
Tong, Lu-Sha
Hu, Xiao
Cao, Wen-Feng
Yan, Wei
Gao, Rui-Jiang
Li, Qi
Wang, Jian-Yi
Liu, Yi
Wang, Bao-Jun
Wang, Xiao-Hua
Yao, Sheng-Tao
Lang, Ye
Li, Hai-Peng
Anderson, Craig S.
Ji, Xun-Ming https://orcid.org/0000-0002-0527-2852
,
Funding for this research was provided by:
Innovative Research Group Project of the National Natural Science Foundation of China (82171278)
Article History
Received: 17 November 2024
Accepted: 19 March 2025
First Online: 8 April 2025
Declarations
:
: This study was registered at ClinicalTrials.gov (NCT05448248). The study was centrally approved by the ethics committee of Hunan Brain Hospital (Z2017006).
: Not applicable.
: CSA reports grant applications from the National Health and Medical Research Council (NHMRC) of Australia, the Medical Research Foundation (MRF) of the United Kingdom, and consulting fees from AstraZeneca.